OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial
Xilin Wu, Russell Senanayake, Emily Goodchild, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 190-202
Open Access | Times Cited: 70
Xilin Wu, Russell Senanayake, Emily Goodchild, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 190-202
Open Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
Molecular Imaging Versus Adrenal Vein Sampling for the Detection of Surgically Curable Primary Aldosteronism
Emily Goodchild, Xilin Wu, Russell Senanayake, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 2
Emily Goodchild, Xilin Wu, Russell Senanayake, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 2
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production
Xilin Wu, Elena Azizan, Emily Goodchild, et al.
Nature Genetics (2023) Vol. 55, Iss. 6, pp. 1009-1021
Open Access | Times Cited: 33
Xilin Wu, Elena Azizan, Emily Goodchild, et al.
Nature Genetics (2023) Vol. 55, Iss. 6, pp. 1009-1021
Open Access | Times Cited: 33
Primary aldosteronism: molecular medicine meets public health
Elena Azizan, William Drake, Morris J. Brown
Nature Reviews Nephrology (2023) Vol. 19, Iss. 12, pp. 788-806
Open Access | Times Cited: 24
Elena Azizan, William Drake, Morris J. Brown
Nature Reviews Nephrology (2023) Vol. 19, Iss. 12, pp. 788-806
Open Access | Times Cited: 24
Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy
Martina Tetti, Denise Brüdgam, Jacopo Burrello, et al.
Hypertension (2024) Vol. 81, Iss. 4, pp. 936-945
Closed Access | Times Cited: 13
Martina Tetti, Denise Brüdgam, Jacopo Burrello, et al.
Hypertension (2024) Vol. 81, Iss. 4, pp. 936-945
Closed Access | Times Cited: 13
A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism
Xuan Yin, Kai Ai, Jian‐Guang Luo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Xuan Yin, Kai Ai, Jian‐Guang Luo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
Daniel Gillett, Russell Senanayake, James MacFarlane, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268425-jnumed.124.268425
Closed Access | Times Cited: 1
Daniel Gillett, Russell Senanayake, James MacFarlane, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268425-jnumed.124.268425
Closed Access | Times Cited: 1
Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial
Giulia Argentesi, Xi‐Lin Wu, Alexander Ney, et al.
The Lancet (2025)
Open Access | Times Cited: 1
Giulia Argentesi, Xi‐Lin Wu, Alexander Ney, et al.
The Lancet (2025)
Open Access | Times Cited: 1
Tools to Predict Unilateral Primary Aldosteronism and Optimise Patient Selection for Adrenal Vein Sampling: A Systematic Review
Elisabeth Ng, Stella May Gwini, Winston Zheng, et al.
Clinical Endocrinology (2025)
Open Access | Times Cited: 1
Elisabeth Ng, Stella May Gwini, Winston Zheng, et al.
Clinical Endocrinology (2025)
Open Access | Times Cited: 1
Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis
Sunil Samnani, Irena Cenzer, Gregory Kline, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 3, pp. e1280-e1289
Open Access | Times Cited: 17
Sunil Samnani, Irena Cenzer, Gregory Kline, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 3, pp. e1280-e1289
Open Access | Times Cited: 17
Clinical Management of Primary Aldosteronism: An Update
Gian Paolo Rossi, Federico Bernardo Rossi, Chiara Guarnieri, et al.
Hypertension (2024) Vol. 81, Iss. 9, pp. 1845-1856
Closed Access | Times Cited: 8
Gian Paolo Rossi, Federico Bernardo Rossi, Chiara Guarnieri, et al.
Hypertension (2024) Vol. 81, Iss. 9, pp. 1845-1856
Closed Access | Times Cited: 8
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Nathan Mullen, James Curneen, Padraig Donlon, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 125-170
Open Access | Times Cited: 16
Nathan Mullen, James Curneen, Padraig Donlon, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 125-170
Open Access | Times Cited: 16
What We Know about and What Is New in Primary Aldosteronism
Natalia Ekman, Ashley Grossman, Dorota Dworakowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 900-900
Open Access | Times Cited: 5
Natalia Ekman, Ashley Grossman, Dorota Dworakowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 900-900
Open Access | Times Cited: 5
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society
Luca Faconti, Spoorthy Kulkarni, Christian Delles, et al.
Journal of Human Hypertension (2023) Vol. 38, Iss. 1, pp. 8-18
Open Access | Times Cited: 11
Luca Faconti, Spoorthy Kulkarni, Christian Delles, et al.
Journal of Human Hypertension (2023) Vol. 38, Iss. 1, pp. 8-18
Open Access | Times Cited: 11
68Ga-pentixafor PET/CT in guiding surgical management of primary aldosteronism
Guoyang Zheng, Jie Ding, Yinjie Gao, et al.
Journal of Clinical & Translational Endocrinology (2025), pp. 100384-100384
Open Access
Guoyang Zheng, Jie Ding, Yinjie Gao, et al.
Journal of Clinical & Translational Endocrinology (2025), pp. 100384-100384
Open Access
Рекомендації Європейського товариства кардіологів ESC 2024 з лікування підвищеного артеріального тиску та гіпертензії
John W. McEvoy, Cian P. McCarthy, Sofie Brouwers, et al.
HYPERTENSION (2025) Vol. 17, Iss. 4, pp. 29-168
Open Access
John W. McEvoy, Cian P. McCarthy, Sofie Brouwers, et al.
HYPERTENSION (2025) Vol. 17, Iss. 4, pp. 29-168
Open Access
A new pathway for primary aldosteronism treatment
Alexander A. C. Leung, Gregory Kline
The Lancet (2025)
Closed Access
Alexander A. C. Leung, Gregory Kline
The Lancet (2025)
Closed Access
Adrenal venous sampling for primary aldosteronism
Gian Paolo Rossi
Elsevier eBooks (2025)
Closed Access
Gian Paolo Rossi
Elsevier eBooks (2025)
Closed Access
Home measurement of 24-hour corticosteroid dynamics in primary aldosteronism
Thomas Upton, Thomas Upton, Isabella Marinelli, et al.
Research Square (Research Square) (2025)
Closed Access
Thomas Upton, Thomas Upton, Isabella Marinelli, et al.
Research Square (Research Square) (2025)
Closed Access
Evaluation of Aldosterone Suppression by Cinnarizine, a Putative Cav1.3 Inhibitor
Elisabeth Ng, Yun-Ni Lee, Angela E. Taylor, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Elisabeth Ng, Yun-Ni Lee, Angela E. Taylor, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to American Heart Association/American College of Cardiology Guidelines
Wanpen Vongpatanasin, Adina F. Turcu
Circulation (2025) Vol. 151, Iss. 10, pp. 653-655
Closed Access
Wanpen Vongpatanasin, Adina F. Turcu
Circulation (2025) Vol. 151, Iss. 10, pp. 653-655
Closed Access
Total or partial adrenalectomy for aldosterone-producing adenoma: can 68Ga-Pentixafor PET/CT predict surgical outcomes?
Wen‐Cai Zheng, Shaoming Chen, Qian-Ren-Shun Qiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Wen‐Cai Zheng, Shaoming Chen, Qian-Ren-Shun Qiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
Nikita Makhnov, Jakob Skov, Tobias Åkerström, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Nikita Makhnov, Jakob Skov, Tobias Åkerström, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
The prognostic value of CXCR4 PET/CT imaging in unilateral primary aldosteronism patients after adrenalectomy
Shuai Shao, Haozhe Xu, Zhuo Xing, et al.
EJNMMI Research (2025) Vol. 15, Iss. 1
Open Access
Shuai Shao, Haozhe Xu, Zhuo Xing, et al.
EJNMMI Research (2025) Vol. 15, Iss. 1
Open Access
